|
|
 |
|
|
|
-
American College of Obstetricians and Gynecologists, and American College of
Medical Genetics. Preconception and prenatal carrier screening for cystic
fibrosis. Clinical and Laboratory Guidelines. American College of Obstetricians
and Gynecologists, Washington, DC;2001.
-
Association for Molecular Pathology statement. Recommendations for
in-house development and operation of molecular diagnostic tests.
American Journal of Clinical Pathology. 1999;111(4):449-463.
-
Barker PE, Watson MS, Ticehurst JR, Colbert JC, O'Connell CD. NIST physical
standards for DNA-based medical testing. Journal of Clinical Laboratory Analysis
2002;16:5-10.
- Bernacki SH, Stankovic AK, Williams LO, et al. Establishment of stably EBV-transformed
cell lines from residual clinical blood samples for use in performance evaluation and
quality assurance in molecular genetic testing. Journal of Molecular Diagnostics
2003;5:227-30.
- Dequeker E, Ramsden S, Grody WW, Stenzel TT, Barton DE. Quality control in
molecular genetic testing. Nature Reviews Genetics 2001;2:717-23.
-
Emons H. The 'RM family'-Identification of all of its members.
Acred Qual Assur 2006;10:690-691
-
Emons H, Fajgelj A, van der Veen AMH, Watters R. New definitions on reference materials.
Accred Qual Assur. 2006;10:576-578.
- Grody WW. Quest for controls in molecular genetics.
Journal of Molecular Diagnostics 2003;5:209-211.
- Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick JR.
Laboratory standards and guidelines for population-based cystic fibrosis carrier
screening. Genet Med 2001;3:149-154.
-
Jarvis M, Iyer RK, Williams LO, Noll WW, et al. A novel method for creating
artificial mutant samples for performance evaluation and quality control in
clinical molecular genetics. Journal of Molecular Diagnostics. 2005;7:247-251.
- O'Connell CD, Atha DH, Jakupciak JP, Amos JA, Richie K. Standardization of PCR
amplification for fragile X trinucleotide repeat measurements. Clinical Genetics
2002;61:13-20.
- Mcgovern MM, Benach, MO, Wallenstein S, Desnick RJ, Keenlyside R (1999)
Quality Assurance in Molecular Genetic Testing Laboratories JAMA,
1999;281:835-840.
- Watson MS, Cutting GR, Desnick RJ, et al. Cystic fibrosis population carier screening:
2004 revision of American College of Medical Genetics mutation panel.
Genetics in Medicine 2004;6:387-391
- Williams LO, Cole EC, Lubin IM, et al. Quality assurance in human molecular
genetics testing: status and recommendations. Archives of Pathology & Laboratory
Medicine 2003;127:1353-8.
- Williams LO, Cole EC:
General recommendations for quality assurance programs
for laboratory molecular genetic tests: final monograph. Centers for Disease
Control and Prevention, Public Health Practice Program Office, Division of Laboratory
Systems.
- Yao R, Rich SA, Schneider E. Validation of sixteen leukemia and lymphoma
cell lines as controls for molecular gene rearrangement assays. Clinical
Chemistry 2002;48:1344-1351.
|
This page last reviewed: 1/17/2007
|
|